₨ Official source-observed price
PKR 485.32
30ml
PKR 16.18 / mL
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 16.18/ mL
Price position24% below medianvs like-for-like peer median
Peer comparators50current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Azithromycin
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01FA
- Strength
- 200 mg/5 mL
- Dosage form
- Dry suspension
- Pack
- 30ml
- Registration no.
- 104218
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Ferozsons Laboratories Limited
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 485.32 | 2026-07-22 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
A-zatro 200 mg/5 mLCaliph Pharmaceuticals (Pvt) Ltd. · PKR 290.35A.Z Ko 250 mgRASCO PHARMA · PKR 525.25A.Z Ko 500 mgRASCO PHARMA · PKR 412.69ACASIA 250 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 418.76ACASIA 250 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 684.68Admira 200 mg/5 mLZephyr Pharmatec (pvt) limited · PKR 345.46Admira 250 mgZephyr Pharmatec (pvt) limited · PKR 533.87Admira 500 mgZephyr Pharmatec (pvt) limited · PKR 261.70
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 104218MedInfoBase. (2026). Azobar 200 mg/5 mL Dry suspension (30ml), Ferozsons Laboratories Limited — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/azobar-200-mg-5-ml-104218-15ml-ferozsons-laboratories-limited/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 104218.
MedInfoBase. Azobar 200 mg/5 mL Dry suspension (30ml), Ferozsons Laboratories Limited — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/azobar-200-mg-5-ml-104218-15ml-ferozsons-laboratories-limited/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 104218.
MedInfoBase (2026) Azobar 200 mg/5 mL Dry suspension (30ml), Ferozsons Laboratories Limited — registration and price record. Available at: https://medinfobase.com/brand/azobar-200-mg-5-ml-104218-15ml-ferozsons-laboratories-limited/ (Accessed: 23 September 2026).
"Azobar 200 mg/5 mL Dry suspension (30ml), Ferozsons Laboratories Limited — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/azobar-200-mg-5-ml-104218-15ml-ferozsons-laboratories-limited/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Azobar 200 mg/5 mL Dry suspension (30ml), Ferozsons Laboratories Limited — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/azobar-200-mg-5-ml-104218-15ml-ferozsons-laboratories-limited/.
Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
